Global Biologics Contract Manufacturing Market Growth (Status and Outlook) 2022-2028
- Category: Business & Services
- Published Date: May 2022
- Publisher: LP Information
- Pages: 104
As the global economy mends, the 2021 growth of Biologics Contract Manufacturing will have significant change from previous year. According to our (LP Information) latest study, the global Biologics Contract Manufacturing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biologics Contract Manufacturing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Biologics Contract Manufacturing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Biologics Contract Manufacturing market, reaching US$ million by the year 2028. As for the Europe Biologics Contract Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Biologics Contract Manufacturing players cover Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., and Boehringer Ingelheim GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
MABs
Recombinant Protein
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oncology
Immunological Disorders
Cardiovascular Disorders (CVDs)
Hematological Disorders
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Wuxi Biologics
Abzena Ltd.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Boehringer Ingelheim GmbH
Lonza
SamsungBiologics
Abbvie
Catalent
Bioreliance
Thermo Fischer (Patheon)
Eurofins CDMO
The United States Biologics Contract Manufacturing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Biologics Contract Manufacturing market, reaching US$ million by the year 2028. As for the Europe Biologics Contract Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Biologics Contract Manufacturing players cover Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., and Boehringer Ingelheim GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
MABs
Recombinant Protein
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oncology
Immunological Disorders
Cardiovascular Disorders (CVDs)
Hematological Disorders
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Wuxi Biologics
Abzena Ltd.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Boehringer Ingelheim GmbH
Lonza
SamsungBiologics
Abbvie
Catalent
Bioreliance
Thermo Fischer (Patheon)
Eurofins CDMO
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics Contract Manufacturing Market Size 2017-2028
2.1.2 Biologics Contract Manufacturing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biologics Contract Manufacturing Segment by Type
2.2.1 MABs
2.2.2 Recombinant Protein
2.2.3 Others
2.3 Biologics Contract Manufacturing Market Size by Type
2.3.1 Biologics Contract Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biologics Contract Manufacturing Market Size Market Share by Type (2017-2022)
2.4 Biologics Contract Manufacturing Segment by Application
2.4.1 Oncology
2.4.2 Immunological Disorders
2.4.3 Cardiovascular Disorders (CVDs)
2.4.4 Hematological Disorders
2.4.5 Others
2.5 Biologics Contract Manufacturing Market Size by Application
2.5.1 Biologics Contract Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biologics Contract Manufacturing Market Size Market Share by Application (2017-2022)
3 Biologics Contract Manufacturing Market Size by Player
3.1 Biologics Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Biologics Contract Manufacturing Revenue by Players (2020-2022)
3.1.2 Global Biologics Contract Manufacturing Revenue Market Share by Players (2020-2022)
3.2 Global Biologics Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologics Contract Manufacturing by Regions
4.1 Biologics Contract Manufacturing Market Size by Regions (2017-2022)
4.2 Americas Biologics Contract Manufacturing Market Size Growth (2017-2022)
4.3 APAC Biologics Contract Manufacturing Market Size Growth (2017-2022)
4.4 Europe Biologics Contract Manufacturing Market Size Growth (2017-2022)
4.5 Middle East & Africa Biologics Contract Manufacturing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biologics Contract Manufacturing Market Size by Country (2017-2022)
5.2 Americas Biologics Contract Manufacturing Market Size by Type (2017-2022)
5.3 Americas Biologics Contract Manufacturing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Contract Manufacturing Market Size by Region (2017-2022)
6.2 APAC Biologics Contract Manufacturing Market Size by Type (2017-2022)
6.3 APAC Biologics Contract Manufacturing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics Contract Manufacturing by Country (2017-2022)
7.2 Europe Biologics Contract Manufacturing Market Size by Type (2017-2022)
7.3 Europe Biologics Contract Manufacturing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologics Contract Manufacturing by Region (2017-2022)
8.2 Middle East & Africa Biologics Contract Manufacturing Market Size by Type (2017-2022)
8.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biologics Contract Manufacturing Market Forecast
10.1 Global Biologics Contract Manufacturing Forecast by Regions (2023-2028)
10.1.1 Global Biologics Contract Manufacturing Forecast by Regions (2023-2028)
10.1.2 Americas Biologics Contract Manufacturing Forecast
10.1.3 APAC Biologics Contract Manufacturing Forecast
10.1.4 Europe Biologics Contract Manufacturing Forecast
10.1.5 Middle East & Africa Biologics Contract Manufacturing Forecast
10.2 Americas Biologics Contract Manufacturing Forecast by Country (2023-2028)
10.2.1 United States Biologics Contract Manufacturing Market Forecast
10.2.2 Canada Biologics Contract Manufacturing Market Forecast
10.2.3 Mexico Biologics Contract Manufacturing Market Forecast
10.2.4 Brazil Biologics Contract Manufacturing Market Forecast
10.3 APAC Biologics Contract Manufacturing Forecast by Region (2023-2028)
10.3.1 China Biologics Contract Manufacturing Market Forecast
10.3.2 Japan Biologics Contract Manufacturing Market Forecast
10.3.3 Korea Biologics Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Biologics Contract Manufacturing Market Forecast
10.3.5 India Biologics Contract Manufacturing Market Forecast
10.3.6 Australia Biologics Contract Manufacturing Market Forecast
10.4 Europe Biologics Contract Manufacturing Forecast by Country (2023-2028)
10.4.1 Germany Biologics Contract Manufacturing Market Forecast
10.4.2 France Biologics Contract Manufacturing Market Forecast
10.4.3 UK Biologics Contract Manufacturing Market Forecast
10.4.4 Italy Biologics Contract Manufacturing Market Forecast
10.4.5 Russia Biologics Contract Manufacturing Market Forecast
10.5 Middle East & Africa Biologics Contract Manufacturing Forecast by Region (2023-2028)
10.5.1 Egypt Biologics Contract Manufacturing Market Forecast
10.5.2 South Africa Biologics Contract Manufacturing Market Forecast
10.5.3 Israel Biologics Contract Manufacturing Market Forecast
10.5.4 Turkey Biologics Contract Manufacturing Market Forecast
10.5.5 GCC Countries Biologics Contract Manufacturing Market Forecast
10.6 Global Biologics Contract Manufacturing Forecast by Type (2023-2028)
10.7 Global Biologics Contract Manufacturing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Wuxi Biologics
11.1.1 Wuxi Biologics Company Information
11.1.2 Wuxi Biologics Biologics Contract Manufacturing Product Offered
11.1.3 Wuxi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Wuxi Biologics Main Business Overview
11.1.5 Wuxi Biologics Latest Developments
11.2 Abzena Ltd.
11.2.1 Abzena Ltd. Company Information
11.2.2 Abzena Ltd. Biologics Contract Manufacturing Product Offered
11.2.3 Abzena Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abzena Ltd. Main Business Overview
11.2.5 Abzena Ltd. Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Latest Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Information
11.4.2 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product Offered
11.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Boehringer Ingelheim GmbH Main Business Overview
11.4.5 Boehringer Ingelheim GmbH Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Biologics Contract Manufacturing Product Offered
11.5.3 Lonza Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 SamsungBiologics
11.6.1 SamsungBiologics Company Information
11.6.2 SamsungBiologics Biologics Contract Manufacturing Product Offered
11.6.3 SamsungBiologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 SamsungBiologics Main Business Overview
11.6.5 SamsungBiologics Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Biologics Contract Manufacturing Product Offered
11.7.3 Abbvie Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Catalent
11.8.1 Catalent Company Information
11.8.2 Catalent Biologics Contract Manufacturing Product Offered
11.8.3 Catalent Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Catalent Main Business Overview
11.8.5 Catalent Latest Developments
11.9 Bioreliance
11.9.1 Bioreliance Company Information
11.9.2 Bioreliance Biologics Contract Manufacturing Product Offered
11.9.3 Bioreliance Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bioreliance Main Business Overview
11.9.5 Bioreliance Latest Developments
11.10 Thermo Fischer (Patheon)
11.10.1 Thermo Fischer (Patheon) Company Information
11.10.2 Thermo Fischer (Patheon) Biologics Contract Manufacturing Product Offered
11.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Thermo Fischer (Patheon) Main Business Overview
11.10.5 Thermo Fischer (Patheon) Latest Developments
11.11 Eurofins CDMO
11.11.1 Eurofins CDMO Company Information
11.11.2 Eurofins CDMO Biologics Contract Manufacturing Product Offered
11.11.3 Eurofins CDMO Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Eurofins CDMO Main Business Overview
11.11.5 Eurofins CDMO Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics Contract Manufacturing Market Size 2017-2028
2.1.2 Biologics Contract Manufacturing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biologics Contract Manufacturing Segment by Type
2.2.1 MABs
2.2.2 Recombinant Protein
2.2.3 Others
2.3 Biologics Contract Manufacturing Market Size by Type
2.3.1 Biologics Contract Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biologics Contract Manufacturing Market Size Market Share by Type (2017-2022)
2.4 Biologics Contract Manufacturing Segment by Application
2.4.1 Oncology
2.4.2 Immunological Disorders
2.4.3 Cardiovascular Disorders (CVDs)
2.4.4 Hematological Disorders
2.4.5 Others
2.5 Biologics Contract Manufacturing Market Size by Application
2.5.1 Biologics Contract Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biologics Contract Manufacturing Market Size Market Share by Application (2017-2022)
3 Biologics Contract Manufacturing Market Size by Player
3.1 Biologics Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Biologics Contract Manufacturing Revenue by Players (2020-2022)
3.1.2 Global Biologics Contract Manufacturing Revenue Market Share by Players (2020-2022)
3.2 Global Biologics Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologics Contract Manufacturing by Regions
4.1 Biologics Contract Manufacturing Market Size by Regions (2017-2022)
4.2 Americas Biologics Contract Manufacturing Market Size Growth (2017-2022)
4.3 APAC Biologics Contract Manufacturing Market Size Growth (2017-2022)
4.4 Europe Biologics Contract Manufacturing Market Size Growth (2017-2022)
4.5 Middle East & Africa Biologics Contract Manufacturing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biologics Contract Manufacturing Market Size by Country (2017-2022)
5.2 Americas Biologics Contract Manufacturing Market Size by Type (2017-2022)
5.3 Americas Biologics Contract Manufacturing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Contract Manufacturing Market Size by Region (2017-2022)
6.2 APAC Biologics Contract Manufacturing Market Size by Type (2017-2022)
6.3 APAC Biologics Contract Manufacturing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics Contract Manufacturing by Country (2017-2022)
7.2 Europe Biologics Contract Manufacturing Market Size by Type (2017-2022)
7.3 Europe Biologics Contract Manufacturing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologics Contract Manufacturing by Region (2017-2022)
8.2 Middle East & Africa Biologics Contract Manufacturing Market Size by Type (2017-2022)
8.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biologics Contract Manufacturing Market Forecast
10.1 Global Biologics Contract Manufacturing Forecast by Regions (2023-2028)
10.1.1 Global Biologics Contract Manufacturing Forecast by Regions (2023-2028)
10.1.2 Americas Biologics Contract Manufacturing Forecast
10.1.3 APAC Biologics Contract Manufacturing Forecast
10.1.4 Europe Biologics Contract Manufacturing Forecast
10.1.5 Middle East & Africa Biologics Contract Manufacturing Forecast
10.2 Americas Biologics Contract Manufacturing Forecast by Country (2023-2028)
10.2.1 United States Biologics Contract Manufacturing Market Forecast
10.2.2 Canada Biologics Contract Manufacturing Market Forecast
10.2.3 Mexico Biologics Contract Manufacturing Market Forecast
10.2.4 Brazil Biologics Contract Manufacturing Market Forecast
10.3 APAC Biologics Contract Manufacturing Forecast by Region (2023-2028)
10.3.1 China Biologics Contract Manufacturing Market Forecast
10.3.2 Japan Biologics Contract Manufacturing Market Forecast
10.3.3 Korea Biologics Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Biologics Contract Manufacturing Market Forecast
10.3.5 India Biologics Contract Manufacturing Market Forecast
10.3.6 Australia Biologics Contract Manufacturing Market Forecast
10.4 Europe Biologics Contract Manufacturing Forecast by Country (2023-2028)
10.4.1 Germany Biologics Contract Manufacturing Market Forecast
10.4.2 France Biologics Contract Manufacturing Market Forecast
10.4.3 UK Biologics Contract Manufacturing Market Forecast
10.4.4 Italy Biologics Contract Manufacturing Market Forecast
10.4.5 Russia Biologics Contract Manufacturing Market Forecast
10.5 Middle East & Africa Biologics Contract Manufacturing Forecast by Region (2023-2028)
10.5.1 Egypt Biologics Contract Manufacturing Market Forecast
10.5.2 South Africa Biologics Contract Manufacturing Market Forecast
10.5.3 Israel Biologics Contract Manufacturing Market Forecast
10.5.4 Turkey Biologics Contract Manufacturing Market Forecast
10.5.5 GCC Countries Biologics Contract Manufacturing Market Forecast
10.6 Global Biologics Contract Manufacturing Forecast by Type (2023-2028)
10.7 Global Biologics Contract Manufacturing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Wuxi Biologics
11.1.1 Wuxi Biologics Company Information
11.1.2 Wuxi Biologics Biologics Contract Manufacturing Product Offered
11.1.3 Wuxi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Wuxi Biologics Main Business Overview
11.1.5 Wuxi Biologics Latest Developments
11.2 Abzena Ltd.
11.2.1 Abzena Ltd. Company Information
11.2.2 Abzena Ltd. Biologics Contract Manufacturing Product Offered
11.2.3 Abzena Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abzena Ltd. Main Business Overview
11.2.5 Abzena Ltd. Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Latest Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Information
11.4.2 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product Offered
11.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Boehringer Ingelheim GmbH Main Business Overview
11.4.5 Boehringer Ingelheim GmbH Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Biologics Contract Manufacturing Product Offered
11.5.3 Lonza Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 SamsungBiologics
11.6.1 SamsungBiologics Company Information
11.6.2 SamsungBiologics Biologics Contract Manufacturing Product Offered
11.6.3 SamsungBiologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 SamsungBiologics Main Business Overview
11.6.5 SamsungBiologics Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Biologics Contract Manufacturing Product Offered
11.7.3 Abbvie Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Catalent
11.8.1 Catalent Company Information
11.8.2 Catalent Biologics Contract Manufacturing Product Offered
11.8.3 Catalent Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Catalent Main Business Overview
11.8.5 Catalent Latest Developments
11.9 Bioreliance
11.9.1 Bioreliance Company Information
11.9.2 Bioreliance Biologics Contract Manufacturing Product Offered
11.9.3 Bioreliance Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bioreliance Main Business Overview
11.9.5 Bioreliance Latest Developments
11.10 Thermo Fischer (Patheon)
11.10.1 Thermo Fischer (Patheon) Company Information
11.10.2 Thermo Fischer (Patheon) Biologics Contract Manufacturing Product Offered
11.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Thermo Fischer (Patheon) Main Business Overview
11.10.5 Thermo Fischer (Patheon) Latest Developments
11.11 Eurofins CDMO
11.11.1 Eurofins CDMO Company Information
11.11.2 Eurofins CDMO Biologics Contract Manufacturing Product Offered
11.11.3 Eurofins CDMO Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Eurofins CDMO Main Business Overview
11.11.5 Eurofins CDMO Latest Developments
12 Research Findings and Conclusion
no record found